Cymabay Therapeu Price on December 11, 2024
| CBAYDelisted Stock | USD 11.83 0.27 2.34% |
If you're considering investing in Cymabay Stock, it is important to understand the factors that can impact its price. As of today, the current price of Cymabay Therapeu stands at 11.83, as last reported on the 12th of December 2024, with the highest price reaching 12.43 and the lowest price hitting 11.52 during the day. We have found eight technical indicators for Cymabay Therapeu, which you can use to evaluate the volatility of the firm. Please confirm Cymabay Therapeu's Day Typical Price of 11.93, accumulation distribution of 0.0732, and Rate Of Daily Change of 1.02 to double-check if the risk estimate we provide is consistent with the expected return of 0.0%.
Cymabay Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Cymabay |
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| CBAY |
Based on monthly moving average Cymabay Therapeu is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cymabay Therapeu by adding Cymabay Therapeu to a well-diversified portfolio.
Related Headline
Terns Pharmaceuticals Headline on 11th of December 2024
Terns Pharmaceuticals CEO Director Acquires 423 percent More... by finance.yahoo.com
Potential Terns Pharmaceuticals, Inc. shareholders may wish to note that the CEO Director, Amy...
Cymabay Therapeu Valuation on December 11, 2024
It is possible to determine the worth of Cymabay Therapeu on a given historical date. On December 11, 2024 Cymabay was worth 11.56 at the beginning of the trading date compared to the closed value of 11.83. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Cymabay Therapeu stock. Still, in general, we apply an absolute valuation method to find Cymabay Therapeu's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Cymabay Therapeu where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Cymabay Therapeu's related companies.
| Open | High | Low | Close | Volume | |
12/12/2024 | 11.56 | 12.43 | 11.52 | 11.83 | 0.00 |
| Backtest Cymabay Therapeu | | | Cymabay Therapeu History | | | Cymabay Therapeu Valuation |
Cymabay Therapeu Trading Date Momentum on December 11, 2024
Cymabay Therapeu Fundamentals Correlations and Trends
By evaluating Cymabay Therapeu's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Cymabay Therapeu's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Cymabay financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Cymabay Therapeu Stock history
Cymabay Therapeu investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cymabay is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cymabay Therapeu will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cymabay Therapeu stock prices may prove useful in developing a viable investing in Cymabay Therapeu
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. CymaBay Therapeutics, Inc. was incorporated in 1988 and is headquartered in Newark, California. Cymabay Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 59 people.
Cymabay Therapeu Stock Technical Analysis
Cymabay Therapeu technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
Price Boundaries
Cymabay Therapeu Period Price Range
Low | December 12, 2024
| High |
0.00 | 0.00 |
Cymabay Therapeu cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Cymabay Therapeu December 12, 2024 Market Strength
Market strength indicators help investors to evaluate how Cymabay Therapeu stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cymabay Therapeu shares will generate the highest return on investment. By undertsting and applying Cymabay Therapeu stock market strength indicators, traders can identify Cymabay Therapeu entry and exit signals to maximize returns
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Consideration for investing in Cymabay Stock
If you are still planning to invest in Cymabay Therapeu check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cymabay Therapeu's history and understand the potential risks before investing.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |